Background: Cigarette smoking is the leading preventable cause of death. Unfortunately, the majority of smokers who attempt to quit smoking relapse within weeks. Abnormal dorsal anterior cingulate cortex (dACC) function may contribute to tobacco smoking relapse vulnerability. Growing evidence suggests that glutamate neurotransmission is involved in mediating nicotine dependence. We hypothesized that prior to a cessation attempt, dACC glutamate levels would be lower in relapse vulnerable smokers. Methods: Proton magnetic resonance spectra (MRS) were obtained from dACC and a control region, the parieto-occipital cortex (POC), using two-dimensional J-resolved MRS at 4 T and analyzed using LCModel. Nine nicotine-dependent women were scanned prior to making a quit attempt. Subjects then were divided into two groups; those able to maintain subsequent abstinence aided by nicotine replacement therapy (NRT) and those who slipped while on NRT (smoked any part of a cigarette after attaining at least 24 h of abstinence). Results: Slip subjects exhibited significantly reduced dACC MRS glutamate (Glu/Cr) levels (p b 0.03) compared to abstinent subjects. This effect was not observed in the POC control region. Conclusions: Our preliminary findings suggest that dACC Glu levels as measured with MRS may help identify and/or be a biomarker for relapse vulnerable smokers. Future research following up on these findings may help clarify the role of dACC Glu in smoking dependence that may lead to new treatment strategies.
Introduction
Tobacco-derived nicotine dependence accounts for nearly 450,000 yearly deaths in the US (DeVita, 2005) . Despite the existence of pharmacotherapies that substantially improve smoking cessation rates when combined with behavioral therapy (Gonzales et al., 2006; Jorenby et al., 2006) , most smokers who quit eventually relapse (Hughes et al., 2003) . Relapse vulnerability and nicotine dependence are associated with disrupted functional connectivity between the dorsal anterior cingulate cortex (dACC) and brain regions implicated in reward and smoking behavior (Hong et al., 2009; Janes et al., 2010) .
Additionally, smokers exhibit increased dACC activation when resisting craving to smoking cues (Brody et al., 2007) , which may reflect greater effort to exert cognitive control over craving (Kerns et al., 2004) . Thus, a disconnect between the dACC and reward-related brain regions could reflect a dysfunctional cognitive control network, and when present could make it more difficult for vulnerable smokers to resist craving, leading to higher relapse vulnerability. Identifying neurobiological markers of dACC dysfunction may help lead to novel smoking cessation and relapse prevention treatments.
In this preliminary study, we hypothesized that relapse vulnerable smokers would have decreased glutamate (Glu) proton metabolite levels in the dACC prior to a cessation attempt. This hypothesis is based on previous work indicating that chronic substance abusers have reduced Glu levels in the ACC. For instance, ACC Glu levels, as measured with proton magnetic resonance spectroscopy (MRS), are decreased in chronic cocaine (Yang et al., 2009 ) and chronic opiate users (Yücel et al., 2007) . Additionally, ACC Glu levels are decreased in individuals with attention deficit hyperactivity disorder (Perlov et al., 2007) , a condition associated with cognitive control dysfunction. Moreover, glutamate has been implicated as playing a role in cognitive control and in coping with cognitive challenges (Cull-Candy et al., 2001) . Collectively, these findings suggest a possible link among ACC
